GLUT2 and glucokinase expression is coordinately regulated by sulfonylurea

Mol Cell Endocrinol. 1999 Jul 20;153(1-2):155-61. doi: 10.1016/s0303-7207(99)00073-8.

Abstract

In the present study we examined the effect of sulfonylurea on the expression of the glucose transporter GLUT2 and the glucose phosphorylating enzyme Glucokinase (GK) in betaTC6-F7 cells; furthermore, we studied the modifications induced by sulfonylurea on glucose-responsiveness and -sensitivity. Results demonstrate that sulfonylurea increases GLUT2 and GK mRNA expression after 24 h in a dose-dependent manner. On the contrary, after 48 and 72 h a time-dependent reduction of both GLUT2 and GK mRNA occurs. GLUT2 and GK protein expression follow the same modifications. Therefore, GLUT2 and GK are coordinately regulated by sulfonylurea, probably by a common mechanism. Glucose-induced insulin release is increased by sulfonylurea as well as glucose sensitivity. Our study suggests that short-term effect of sulfonylurea increases while long-term effect reduces the expression of glucose sensing elements. The long-term inhibitory effect on glucose sensing elements would explain the reduced insulin secretion occurring after chronic sulfonylurea treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Gene Expression Regulation / drug effects*
  • Glucokinase / genetics*
  • Glucose / pharmacology
  • Glucose Transporter Type 2
  • Hypoglycemic Agents / pharmacology*
  • Insulin / metabolism
  • Insulin Secretion
  • Insulinoma
  • Kinetics
  • Mice
  • Mice, Transgenic
  • Monosaccharide Transport Proteins / genetics*
  • Pancreatic Neoplasms
  • RNA, Messenger / metabolism
  • Sulfonylurea Compounds / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Glucose Transporter Type 2
  • Hypoglycemic Agents
  • Insulin
  • Monosaccharide Transport Proteins
  • RNA, Messenger
  • Sulfonylurea Compounds
  • glimepiride
  • Glucokinase
  • Glucose